Just watch how this plays out. The first comment on the JAMA Oncology article challenges the validity of the NWBO trial and then Journal of Neuro-Oncology Editorial documents a series of issues with the trial. The hits just keep on coming. And you send me links to the Spoofing lawsuit?? Really?
Market Data 
Markets 
AI
